Causeway Sensors

Causeway Sensors Ltd. specializes in developing and manufacturing nanotechnology-based point-of-care diagnostic solutions for rapid disease detection. Established in 2013 and headquartered in Belfast, United Kingdom, the company offers a compact biosensor known as The Affinity, which features a chip embedded with a billion gold nanorods. This innovative design allows for sensitive detection of biological events at the chip’s surface. The Affinity biosensor, along with its Access Chip, is intended for biochemistry researchers and provides real-time analysis at an accessible price. Additionally, Causeway Sensors' technology aids pharmaceutical companies by enabling quick data capture during candidate screening for new biological drugs, ultimately helping to reduce development times and costs while improving the quality of drugs.